Comparison

TherapySelector vs HIV

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

TherapySelector

This app assists physicians in selecting personalized treatment plans for hypertension and hepatitis C. It analyzes patient data to provide information on medication effectiveness, adverse events, and costs, supporting informed decisions during consultations.

Highlights
  • Patient profile determination based on 4 questions
  • Medication effectiveness and adverse event probability
  • Treatment cost information
  • Hypertension therapy options (THZ, CCA, ACEi, ARB)
  • Monotherapy and stepwise addition guidance
  • Available in English and Dutch
Read full description

TherapySelector supports you as a physician to easily and quickly choose a data-based, person-centered treatment for hypertension and hepatitis C for and with your patient during consultation hours. The app shows in a single glance information about the effectiveness of medication based on the disease remission (systolic blood pressure lower than 140 mmHg for hypertension and viral clearance in hepatitis C), the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best person-centered treatment method for your patient, based on study data. How does TherapySelector work? First you enter the requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on frequently updated study results. For each therapy you find information about effectiveness, possible adverse events and costs. TherapySelector currently provides the following features: • Determination of patient profiles based on four simple questions about the patient. • Probability of "success" of all registered medication (combinations) for hypertension and hepatitis C, together with the probability of adverse events associated with the patient profile, based on individual patient data from key clinical scientific studies. • For hypertension: overview of therapy options with Thiazide diuretics (THZ), Calcium Channel Blockers (CCA), ACE inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB). Information on monotherapy with dose increase (Titrate), and results of stepwise addition of medication (Titrate & Add). • Detail information, including information about dosage (of the therapy regime) and the cost of a specific treatment. • Availability in both English and Dutch. TherapySelector is intended to provide physicians and patients person-centered information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are based on the ‘average’ patient. The TherapySelector app can be used without creating an account. Developed with (academic) medical centers and research institutes TherapySelector is developed by TherapySelector in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data in the app has been authorized by specialists from Dutch scientific associations. The results are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose. About TherapySelector TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with person-centered treatment information based on the most recent data from scientific studies. It is not our goal to make profit. With the TherapySelector app, we facilitate doctors with person-centered care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment. Follow us on LinkedIn (https://www.linkedin.com/company/therapyselector) or visit www.therapyselector.com.

About

HIV

This app provides practicing clinicians with information on HIV medications and potential drug interactions with commonly co-prescribed HCV and Primary Care medications. It includes sections on HIV-HCV interactions, HCV-Primary Care medication interactions, drug metabolism, and links to external resources for clinical support.

Highlights
  • HIV-HCV drug interaction checker
  • HCV-Primary Care medication interaction data
  • Drug metabolism information
  • Links to clinical support resources
  • DHHS HIV Guidelines data
Features
Read full description

Application Description: This application was developed with funding from the Northeast/Caribbean AIDS Education and Training Center Program and was designed for practicing clinicians to provide information on HIV medications and drug interactions with commonly co-prescribed HCV and Primary Care medications. The four tabs at the bottom of the application include: HIV-HCV Interactions, HCV-Primary Care Medications Interactions, Drug Metabolism, and Common Web Resources. The Common Web Resources tab contains links to external websites and phone numbers for information and national warmlines that provide clinical support with HIV care, substance use, Hepatitis C, and COVID-19. The data set for the drug interaction output for this application was developed using the Department of Health and Human Services Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV and other various sources. The application was developed and launched under the direction of VirologyEd Consultants, LLC.  Disclaimer: The information contained in this application has been developed from various resources, however majority of information is from the DHHS HIV Guidelines referenced below. While the information contained in this has been reviewed, users should be aware that there may be contraindicated or combinations that may lead to adverse events that are not contained here. As with any drug interaction resource, providers are encouraged to consult additional references to verify information prior to making clinical decisions. These guidelines are for informational purposes only and cannot identify medical risks specific to an individual patient or recommend patient treatment. The absence of typographical errors is not guaranteed. These guidelines are not necessarily all-inclusive. Use of these guidelines indicates acknowledgement that neither Northeast/Caribbean AETC, nor the authors will be responsible for any loss or injury, sustained in connection with, or as a result of, the use of these guidelines. Users of this guide should consult other sources before prescribing medications or treatment. HRSA disclosure: Funding for this presentation was made possible by TR753197 from the Health Resources and Services Administration’s HIV/AIDS Bureau. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for products mentioned during this presentation are for training and identification purposes only.

Screenshots

TherapySelector4 screens
HIV2 screens

Verdict

The call

The clearest difference is rating: HIV at 5.0 against TherapySelector's 3.0. TherapySelector's advantage is update cadence (every 3 months vs every 7 months). On price, ratings volume, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

HIV holds the better App Store score, 5.0 against 3.0. Both are backed by a comparable volume of ratings — 2 and 1 respectively.

UpkeepUpdate frequency

TherapySelector ships an update every 3 months, HIV every 7 months. The most recent releases landed on November 16, 2026 and November 3, 2026 respectively.

Scorecard2 real differences · 7 level
TherapySelector versus HIV: the parameters behind the verdict, then further details
ParameterTherapySelectorHIV
PriceFreeFree
Rating3.0 (2 ratings)5.0 (1 ratings) — better
Number of ratings2 — better1
Update frequencyEvery 3 months — betterEvery 7 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS12.0 — better13.0
Further details — not scored
Size26 MB19 MB
Age rating17+4+
DeveloperTherapySelector B.V.VirologyEd Consultants, LLC

Customer experience

TherapySelector

All ratings2 ratings
Positive50.0%
Neutral0.0%
Negative50.0%

HIV

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

TherapySelector

No in-app purchases

None

HIV

No in-app purchases

Questions

Is TherapySelector free?
TherapySelector is free to download, with no in-app purchases.
Is HIV free?
HIV is free to download, with no in-app purchases.
Which has better reviews, TherapySelector or HIV?
HIV is rated higher. TherapySelector averages 3.0 out of 5 from 2 ratings, while HIV averages 5.0 from 1 ratings.
Do TherapySelector or HIV have ads?
Neither TherapySelector nor HIV shows ads.
Which is updated more often, TherapySelector or HIV?
TherapySelector ships an update every 3 months, and HIV every 7 months. Most recently, TherapySelector was updated on November 16, 2026 and HIV on November 3, 2026.

Other comparisons